Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment

References

• de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374–22. doi:10.1016/j.ccell.2023.02.016.
   PubMed Web of Science ®Google Scholar
• Bader JE, Voss K, Rathmell JC. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol Cell. 2020;78(6):1019–1033. doi:10.1016/j.molcel.2020.05.034.
   PubMed Web of Science ®Google Scholar
• Bejarano L, Jordāo MJC, Joyce JA. Therapeutic Targeting of the tumor microenvironment. Cancer Discov. 2021;11(4):933–959. doi:10.1158/2159-8290.CD-20-1808.
   PubMed Web of Science ®Google Scholar
• Pitt JM, Marabelle A, Eggermont A, Soria JC, Kroemer G, Zitvogel L. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. 2016;27(8):1482–1492. doi:10.1093/annonc/mdw168.
   PubMed Web of Science ®Google Scholar
• Xiang X, Wang J, Lu D, Xu X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Target Ther. 2021;6(1). doi:10.1038/s41392-021-00484-9.
   Web of Science ®Google Scholar
• Cheng N, Bai X, Shu Y, Ahmad O, Shen P. Targeting tumor-associated macrophages as an antitumor strategy. Biochem Pharmacol. 2021;183:114354. doi:10.1016/j.bcp.2020.114354.
   PubMed Web of Science ®Google Scholar
• Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton J, Ivashkiv L, Lawrence T, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14–20. doi:10.1016/j.immuni.2014.06.008.
   PubMed Web of Science ®Google Scholar
• Funes SC, Rios M, Escobar-Vera J, Kalergis AM. Implications of macrophage polarization in autoimmunity. Immunology. 2018;154(2):186–195. doi:10.1111/imm.12910.
   PubMed Web of Science ®Google Scholar
• Zhang SY, Song XY, Li Y, Ye LL, Zhou Q, Yang WB. Tumor-associated macrophages: a promising target for a cancer immunotherapeutic strategy. Pharmacol Res. 2020;161:105111. doi:10.1016/j.phrs.2020.105111.
   PubMed Web of Science ®Google Scholar
• Kåhrström CT, Pariente N, Weiss U. Intestinal microbiota in health and disease. Nature. 2016;535(7610):47. doi:10.1038/535047a.
   PubMed Web of Science ®Google Scholar
• Kuziel GA, Rakoff-Nahoum S. The gut microbiome. Curr Biol. 2022;32(6):R257–R64. doi:10.1016/j.cub.2022.02.023.
   PubMed Web of Science ®Google Scholar
• Shapira M. Gut microbiotas and host evolution: scaling up symbiosis. Trends Ecol Evol. 2016;31(7):539–549. doi:10.1016/j.tree.2016.03.006.
   PubMed Web of Science ®Google Scholar
• Shi N, Li N, Duan X, Niu H. Interaction between the gut microbiome and mucosal immune system. Mil Med Res. 2017;4(1):14. doi:10.1186/s40779-017-0122-9.
   PubMedGoogle Scholar
• Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16(1):35–56. doi:10.1038/s41575-018-0061-2.
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. doi:10.1038/s41579-020-0433-9.
   PubMed Web of Science ®Google Scholar
• Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature. 2016;535(7610):65–74. doi:10.1038/nature18847.
   PubMed Web of Science ®Google Scholar
• Hekmatshoar Y, Rahbar Saadat Y, Hosseiniyan Khatibi SM, Ozkan T, Zununi Vahed F, Nariman-Saleh-Fam Z, Pourghassem Gargari B, Sunguroglu A, Zununi Vahed S. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental? Life Sci. 2019;233:116680. doi:10.1016/j.lfs.2019.116680.
   PubMed Web of Science ®Google Scholar
• Wei M-Y, Shi S, Liang C, Meng QC, Hua J, Zhang YY, Liu J, Zhang B, Xu J, Yu XJ. The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer. 2019;18(1):97. doi:10.1186/s12943-019-1008-0.
   PubMed Web of Science ®Google Scholar
• Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 2021;21(10):653–667. doi:10.1038/s41577-021-00534-x.
   PubMed Web of Science ®Google Scholar
• Pittet MJ, Michielin O, Migliorini D. Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol. 2022;19(6):402–421. doi:10.1038/s41571-022-00620-6.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li L, Xu C, Wang Y, Wang Z, Chen M, Jiang Z, Pan J, Yang C, Li X, et al. Cross-talk between the gut microbiota and monocyte-like macrophages mediates an inflammatory response to promote colitis-associated tumourigenesis. Gut. 2020;70(8):1495–1506. doi:10.1136/gutjnl-2020-320777.
   PubMed Web of Science ®Google Scholar
• Tan-Garcia A, Wai LE, Zheng D, Ceccarello E, Jo J, Banu N, Khakpoor A, Chia A, Tham CYL, Tan AT, et al. Intrahepatic CD206 macrophages contribute to inflammation in advanced viral-related liver disease. J Hepatol. 2017;67(3):490–500. doi:10.1016/j.jhep.2017.04.023.
   PubMed Web of Science ®Google Scholar
• Jeong JJ, Kim KA, Hwang YJ, Han MJ, Kim DH. Anti-inflammaging effects of Lactobacillus brevis OW38 in aged mice. Benef Microbes. 2016;7(5):707–718. doi:10.3920/BM2016.0016.
   PubMed Web of Science ®Google Scholar
• Kim KA, Jeong JJ, Yoo SY, Kim DH. Gut microbiota lipopolysaccharide accelerates inflamm-aging in mice. BMC Microbiol. 2016;16(1):9. doi:10.1186/s12866-016-0625-7.
   PubMedGoogle Scholar
• West MA, Heagy W. Endotoxin tolerance: a review. Crit Care Med. 2002;30(Suppl.):S64–S73. doi:10.1097/00003246-200201001-00009.
   Google Scholar
• Chu CH, Wang S, Li CL, Chen SH, Hu CF, Chung YL, Chen SL, Wang Q, Lu RB, Gao HM, et al. Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals. Brain Behav Immun. 2016;55:260–272. doi:10.1016/j.bbi.2016.04.015.
   PubMed Web of Science ®Google Scholar
• Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, Olson OC, Quick ML, Huse JT, Teijeiro V, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 2013;19(10):1264–1272. doi:10.1038/nm.3337.
   PubMed Web of Science ®Google Scholar
• Rajaiah R, Perkins DJ, Polumuri SK, Zhao A, Keegan AD, Vogel SN. Dissociation of endotoxin tolerance and differentiation of alternatively activated macrophages. J Immunol. 2013;190(9):4763–4772. doi:10.4049/jimmunol.1202407.
   PubMed Web of Science ®Google Scholar
• Haschemi A, Kosma P, Gille L, Evans CR, Burant CF, Starkl P, Knapp B, Haas R, Schmid J, Jandl C, et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab. 2012;15(6):813–826. doi:10.1016/j.cmet.2012.04.023.
   PubMed Web of Science ®Google Scholar
• Agirman G, Yu KB, Hsiao EY. Signaling inflammation across the gut-brain axis. Sci. 2021;374(6571):1087–1092. doi:10.1126/science.abi6087.
   PubMed Web of Science ®Google Scholar
• Martin CR, Osadchiy V, Kalani A, Mayer EA. The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol. 2018;6(2):133–148. doi:10.1016/j.jcmgh.2018.04.003.
   PubMed Web of Science ®Google Scholar
• Eicher TP, Mohajeri MH. Overlapping mechanisms of action of brain-active bacteria and bacterial metabolites in the pathogenesis of common brain diseases. Nutrients. 2022;14(13):2661. doi:10.3390/nu14132661.
   PubMed Web of Science ®Google Scholar
• D’Alessandro G, Lauro C, Quaglio D, Ghirga F, Botta B, Trettel F, Limatola C. Neuro-Signals from Gut Microbiota: Perspectives for Brain Glioma. Cancers Basel. 2021;13(11):2810. doi:10.3390/cancers13112810.
   PubMed Web of Science ®Google Scholar
• Herbreteau A, Aubert P, Croyal M, Naveilhan P, Billon-Crossouard S, Neunlist M, Delneste Y, Couez D, Aymeric L. Late-stage glioma is associated with deleterious alteration of gut bacterial metabolites in mice. Metabolites. 2022;12(4):290. doi:10.3390/metabo12040290.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao L, Zhang H, Zhang Y, Ju H, Wang X, Ren H, Zhu X, Dong Y. The immunosuppressive microenvironment and immunotherapy in human glioblastoma. Front Immunol. 2022;13:1003651. doi:10.3389/fimmu.2022.1003651.
   PubMedGoogle Scholar
• Wang L, Li S, Fan H, Han M, Xie J, Du J, Peng F. Bifidobacterium lactis combined with Lactobacillus plantarum inhibit glioma growth in mice through modulating PI3K/AKT pathway and gut microbiota. Front Microbiol. 2022;13:986837. doi:10.3389/fmicb.2022.986837.
   PubMed Web of Science ®Google Scholar
• Qin T, Wang C, Chen X, Duan C, Zhang X, Zhang J, Chai H, Tang T, Chen H, Yue J, et al. Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma. Toxicol Appl Pharmacol. 2015;286(2):112–123. doi:10.1016/j.taap.2015.03.021.
   PubMed Web of Science ®Google Scholar
• Sivaprakasam S, Prasad PD, Singh N. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacology & Therapeutics. 2016;164:144–151. doi:10.1016/j.pharmthera.2016.04.007.
   PubMed Web of Science ®Google Scholar
• Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014;111(6):2247–2252. doi:10.1073/pnas.1322269111.
   PubMed Web of Science ®Google Scholar
• Liu T, Li J, Liu Y, Xiao N, Suo H, Xie K, Yang C, Wu C. Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264.7 cells. Inflammation. 2012;35(5):1676–1684. doi:10.1007/s10753-012-9484-z.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang J, Liu H, Huang R, Yan X, Song M, Tan G, Zhi F. Ketone body β-hydroxybutyrate ameliorates colitis by promoting M2 macrophage polarization through the STAT6-dependent signaling pathway. BMC Med. 2022;20(1):148. doi:10.1186/s12916-022-02352-x.
   PubMed Web of Science ®Google Scholar
• Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278(13):11312–11319. doi:10.1074/jbc.M211609200.
   PubMed Web of Science ®Google Scholar
• Ji J, Shu D, Zheng M, Wang J, Luo C, Wang Y, Guo F, Zou X, Lv X, Li Y, et al. Microbial metabolite butyrate facilitates M2 macrophage polarization and function. Sci Rep. 2016;6(1):24838. doi:10.1038/srep24838.
   PubMedGoogle Scholar
• Liang L, Liu L, Zhou W, Yang C, Mai G, Li H, Chen Y. Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage/WNT/ERK signaling pathway. Clin Sci (Lond). 2022;136(4):291–307. doi:10.1042/CS20210778.
   PubMed Web of Science ®Google Scholar
• Cholan PM, Han A, Woodie BR, Watchon M, Kurz AR, Laird AS, Britton WJ, Ye L, Holmes ZC, McCann JR, et al. Conserved anti-inflammatory effects and sensing of butyrate in zebrafish. Gut Microbes. 2020;12(1):1–11. doi:10.1080/19490976.2020.1824563.
   PubMed Web of Science ®Google Scholar
• Ma H, Yu Y, Wang M, Li Z, Xu H, Tian C, Zhang J, Ye X, Li X. Correlation between microbes and colorectal cancer: tumor apoptosis is induced by sitosterols through promoting gut microbiota to produce short-chain fatty acids. Apoptosis. 2019;24(1–2):168–183. doi:10.1007/s10495-018-1500-9.
   PubMed Web of Science ®Google Scholar
• Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661–672. doi:10.1038/nrmicro3344.
   PubMed Web of Science ®Google Scholar
• Funabashi M, Grove TL, Wang M, Varma Y, McFadden ME, Brown LC, Guo C, Higginbottom S, Almo SC, Fischbach MA, et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature. 2020;582(7813):566–570. doi:10.1038/s41586-020-2396-4.
   PubMed Web of Science ®Google Scholar
• Liu L, Dong W, Wang S, Zhang Y, Liu T, Xie R, Wang B, Cao H. Deoxycholic acid disrupts the intestinal mucosal barrier and promotes intestinal tumorigenesis. Food Funct. 2018;9(11):5588–5597. doi:10.1039/C8FO01143E.
   PubMed Web of Science ®Google Scholar
• Cao H, Xu M, Dong W, Deng B, Wang S, Zhang Y, Wang S, Luo S, Wang W, Qi Y, et al. Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis. Int J Cancer. 2017;140(11):2545–2556. doi:10.1002/ijc.30643.
   PubMed Web of Science ®Google Scholar
• Kuroda T, Kitadai Y, Tanaka S, Yang X, Mukaida N, Yoshihara M, Chayama K. Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment. Clin Cancer Res. 2005;11(21):7629–7636. doi:10.1158/1078-0432.CCR-05-0798.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu J, Ren X, Zhang Y, Ke Z, Zhou J, Wang Y, Zhang Y, Liu Y. Cholecystectomy-induced secondary bile acids accumulation ameliorates colitis through inhibiting monocyte/macrophage recruitment. Gut Microbes. 2022;14(1):2107387. doi:10.1080/19490976.2022.2107387.
   PubMed Web of Science ®Google Scholar
• Li Q, Ma L, Shen S, Guo Y, Cao Q, Cai X, Feng J, Yan Y, Hu T, Luo S, et al. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment. J Exp Clin Cancer Res. 2019;38(1):303. doi:10.1186/s13046-019-1271-3.
   PubMed Web of Science ®Google Scholar
• Yao RR, Li JH, Zhang R, Chen RX, Wang YH. M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway. World J Surg Oncol. 2018;16(1):9. doi:10.1186/s12957-018-1312-y.
   PubMed Web of Science ®Google Scholar
• Wang S, Dong W, Liu L, Xu M, Wang Y, Liu T, Zhang Y, Wang B, Cao H. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis. Mol Carcinog. 2019;58(7):1155–1167. doi:10.1002/mc.22999.
   PubMed Web of Science ®Google Scholar
• Wang L, Gong Z, Zhang X, Zhu F, Liu Y, Jin C, Du X, Xu C, Chen Y, Cai W, et al. Gut microbial bile acid metabolite skews macrophage polarization and contributes to high-fat diet-induced colonic inflammation. Gut Microbes. 2020;12(1):12. doi:10.1080/19490976.2020.1819155.
   Web of Science ®Google Scholar
• Ridlon JM, Wolf PG, Gaskins HR. Taurocholic acid metabolism by gut microbes and colon cancer. Gut Microbes. 2016;7(3):201–215. doi:10.1080/19490976.2016.1150414.
   PubMed Web of Science ®Google Scholar
• Cheng K, Raufman JP. Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem Pharmacol. 2005;70(7):1035–1047. doi:10.1016/j.bcp.2005.07.023.
   PubMed Web of Science ®Google Scholar
• Biagioli M, Carino A, Fiorucci C, Marchianò S, Di Giorgio C, Bordoni M, Roselli R, Baldoni M, Distrutti E, Zampella A, et al. The bile acid receptor GPBAR1 modulates CCL2/CCR2 signaling at the liver Sinusoidal/macrophage interface and reverses acetaminophen-induced liver toxicity. J Immunol. 2020;204(9):2535–2551. doi:10.4049/jimmunol.1901427.
   PubMed Web of Science ®Google Scholar
• Biagioli M, Carino A, Cipriani S, Francisci D, Marchianò S, Scarpelli P, Sorcini D, Zampella A, Fiorucci S. The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of GPBAR1 rescues mice from murine colitis. J Immunol. 2017;199(2):718–733. doi:10.4049/jimmunol.1700183.
   PubMed Web of Science ®Google Scholar
• Yu J, Li S, Guo J, Xu Z, Zheng J, Sun X. Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis. Cell Death Disease. 2020;11(8):640. doi:10.1038/s41419-020-02819-w.
   PubMed Web of Science ®Google Scholar
• Yan T, Yan N, Wang H, Yagai T, Luo Y, Takahashi S, Zhao M, Krausz KW, Wang G, Hao H, et al. FXR-Deoxycholic acid-TNF-α axis modulates acetaminophen-induced hepatotoxicity. Toxicol Sci. 2021;181(2):273–284. doi:10.1093/toxsci/kfab027.
   PubMed Web of Science ®Google Scholar
• Zeng H, Umar S, Rust B, Lazarova D, Bordonaro M. Secondary bile acids and short chain fatty acids in the colon: a focus on colonic microbiome, cell proliferation, inflammation, and cancer. Int J Mol Sci. 2019;20(5):1214. doi:10.3390/ijms20051214.
   PubMed Web of Science ®Google Scholar
• Shao J, Ge T, Tang C, Wang G, Pang L, Chen Z. Synergistic anti-inflammatory effect of gut microbiota and lithocholic acid on liver fibrosis. Inflamm Res. 2022;71(10–11):1389–1401. doi:10.1007/s00011-022-01629-4.
   PubMed Web of Science ®Google Scholar
• Hosseinkhani F, Heinken A, Thiele I, Lindenburg PW, Harms AC, Hankemeier T. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut Microbes. 2021;13(1). doi:10.1080/19490976.2021.1882927.
   PubMed Web of Science ®Google Scholar
• Han GH, Kim SJ, Ko WK, Lee D, Han IB, Sheen SH, Hong JB, Sohn S. Transplantation of tauroursodeoxycholic acid–inducing M2-phenotype macrophages promotes an anti-neuroinflammatory effect and functional recovery after spinal cord injury in rats. Cell Prolif. 2021;54(6):e13050. doi:10.1111/cpr.13050.
   PubMed Web of Science ®Google Scholar
• Gao J, Xu K, Liu H, Liu G, Bai M, Peng C, Li T, Yin Y. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Microbiol. 2018;8:13. doi:10.3389/fcimb.2018.00013.
   PubMed Web of Science ®Google Scholar
• Hezaveh K, Shinde RS, Klötgen A, Halaby MJ, Lamorte S, Ciudad MT, Quevedo R, Neufeld L, Liu ZQ, Jin R, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55(2):324–340.e8. doi:10.1016/j.immuni.2022.01.006.
   PubMed Web of Science ®Google Scholar
• Cervantes-Barragan L, Chai JN, Tianero MD, Di Luccia B, Ahern PP, Merriman J, Cortez VS, Caparon MG, Donia MS, Gilfillan S, et al. Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells. Sci. 2017;357(6353):806–810. doi:10.1126/science.aah5825.
   PubMed Web of Science ®Google Scholar
• Shinde R, McGaha TL. The aryl hydrocarbon receptor: connecting immunity to the microenvironment. Trends Immunol. 2018;39(12):1005–1020. doi:10.1016/j.it.2018.10.010.
   PubMed Web of Science ®Google Scholar
• Schiering C, Wincent E, Metidji A, Iseppon A, Li Y, Potocnik AJ, Omenetti S, Henderson CJ, Wolf CR, Nebert DW, et al. Feedback control of AHR signalling regulates intestinal immunity. Nature. 2017;542(7640):242–245. doi:10.1038/nature21080.
   PubMed Web of Science ®Google Scholar
• Frankel TL, Pasca di Magliano M. Immune sensing of microbial metabolites: action at the tumor. Immunity. 2022;55(2):192–194. doi:10.1016/j.immuni.2022.01.009.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang G, Bai J, Zhao N, Wang Q, Zhou R, Li G, Hu C, Li X, Tao K, et al. Role of indole-3-acetic acid in NAFLD amelioration after sleeve Gastrectomy. Obes Surg. 2021;31(7):3040–3052. doi:10.1007/s11695-021-05321-0.
   PubMed Web of Science ®Google Scholar
• Yang X, Liu H, Ye T, Duan C, Lv P, Wu X, Liu J, Jiang K, Lu H, Yang H, et al. AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization. Theranostics. 2020;10(26):12011–12025. doi:10.7150/thno.51144.
   PubMed Web of Science ®Google Scholar
• Wu PY, Yu IS, Lin YC, Chang YT, Chen CC, Lin KH, Tseng TH, Kargren M, Tai YL, Shen TL, et al. Activation of aryl hydrocarbon receptor by kynurenine impairs progression and metastasis of neuroblastoma. Cancer Res. 2019;79(21):5550–5562. doi:10.1158/0008-5472.CAN-18-3272.
   PubMed Web of Science ®Google Scholar
• Takenaka MC, Gabriely G, Rothhammer V, Mascanfroni ID, Wheeler MA, Chao CC, Gutiérrez-Vázquez C, Kenison J, Tjon EC, Barroso A, et al. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nat Neurosci. 2019;22(5):729–740. doi:10.1038/s41593-019-0370-y.
   PubMed Web of Science ®Google Scholar
• Ohue-Kitano R, Yasuoka Y, Goto T, Kitamura N, Park SB, Kishino S, Kimura I, Kasubuchi M, Takahashi H, Li Y, et al. α-linolenic acid-derived metabolites from gut lactic acid bacteria induce differentiation of anti-inflammatory M2 macrophages through G protein-coupled receptor 40. FASEB J. 2018;32(1):304–318. doi:10.1096/fj.201700273R.
   PubMed Web of Science ®Google Scholar
• Zhang A, Xu Y, Xu H, Ren J, Meng T, Ni Y, Zhu Q, Zhang WB, Pan YB, Jin J, et al. Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17. Theranostics. 2021;11(8):3839–3852. doi:10.7150/thno.53749.
   PubMed Web of Science ®Google Scholar
• Mirji G, Worth A, Bhat SA, El Sayed M, Kannan T, Goldman AR, Tang HY, Liu Q, Auslander N, Dang CV, et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Sci Immunol. 2022;7(75):eabn0704. doi:10.1126/sciimmunol.abn0704.
   PubMed Web of Science ®Google Scholar
• Shi Z, Fultz RS, Engevik MA, Gao C, Hall A, Major A, Mori-Akiyama Y, Versalovic J. Distinct roles of histamine H1- and H2-receptor signaling pathways in inflammation-associated colonic tumorigenesis. Am J Physiol Gastrointest Liver Physiol. 2019;316(1):G205–G216. doi:10.1152/ajpgi.00212.2018.
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Mimura K, Ashizawa M, Okayama H, Endo E, Saito K, Sakamoto W, Fujita S, Endo H, Saito M, et al. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers. Cancer Immunol Immunother. 2020;69(1):23–32. doi:10.1007/s00262-019-02433-6.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang Y, Zhao J, Jiang J, Zhou Y, Shi P, Liu Q, Sun Y. Dietary nondigestible polysaccharides ameliorate colitis by improving gut microbiota and CD4+ differentiation, as well as facilitating M2 macrophage polarization. JPEN J Parenter Enteral Nutr. 2019;43(3):401–411. doi:10.1002/jpen.1427.
   PubMed Web of Science ®Google Scholar
• Liu C, Chikina M, Deshpande R, Menk AV, Wang T, Tabib T, Brunazzi EA, Vignali KM, Sun M, Stolz DB, et al. Treg cells promote the SREBP1-dependent metabolic Fitness of tumor-promoting macrophages via repression of CD8+ T cell-derived interferon-γ. Immunity. 2019;51(2):381–397.e6. doi:10.1016/j.immuni.2019.06.017.
   PubMed Web of Science ®Google Scholar
• Campesato LF, Budhu S, Tchaicha J, Weng CH, Gigoux M, Cohen IJ, Redmond D, Mangarin L, Pourpe S, Liu C, et al. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nat Commun. 2020;11(1):4011. doi:10.1038/s41467-020-17750-z.
   PubMed Web of Science ®Google Scholar
• Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341–352. doi:10.1038/nri.2016.42.
   PubMed Web of Science ®Google Scholar
• Li R, Zhou R, Wang H, Li W, Pan M, Yao X, Zhan W, Yang S, Xu L, Ding Y, et al. Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer. Cell Death Differ. 2019;26(11):2447–2463. doi:10.1038/s41418-019-0312-y.
   PubMed Web of Science ®Google Scholar
• Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler C, Ismagilov R, Mazmanian S, Hsiao E, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264–276. doi:10.1016/j.cell.2015.02.047.
   PubMed Web of Science ®Google Scholar
• Yang M, Fukui H, Eda H, Kitayama Y, Hara K, Kodani M, Tomita T, Oshima T, Watari J, Miwa H, et al. Involvement of gut microbiota in the association between gastrointestinal motility and 5‑HT expression/M2 macrophage abundance in the gastrointestinal tract. Mol Med Rep. 2017;16(3):3482–3488. doi:10.3892/mmr.2017.6955.
   PubMed Web of Science ®Google Scholar
• de las Casas-Engel M, Domínguez-Soto A, Sierra-Filardi E, Bragado R, Nieto C, Puig-Kroger A, de las Casas-Engel M, Samaniego R, Loza M, Corcuera MT, et al. Serotonin skews human macrophage polarization through HTR2B and HTR7. J Immunol. 2013;190(5):2301–2310. doi:10.4049/jimmunol.1201133.
   PubMed Web of Science ®Google Scholar
• Sola-Penna M, Paixão LP, Branco JR, Ochioni AC, Albanese JM, Mundim DM, Baptista-de-Souza D, Figueiredo CP, Coelho WS, Marcondes MC, et al. Serotonin activates glycolysis and mitochondria biogenesis in human breast cancer cells through activation of the Jak1/STAT3/ERK1/2 and adenylate cyclase/PKA, respectively. Br J Cancer. 2020;122(2):194–208. doi:10.1038/s41416-019-0640-1.
   PubMed Web of Science ®Google Scholar
• Mola S, Pandolfo C, Sica A, Porta C. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance. Int J Mol Sci. 2020;21(18):6866. doi:10.3390/ijms21186866.
   PubMed Web of Science ®Google Scholar
• Ni H, Chen Y, Xia W, Wang C, Hu C, Sun L, Tang W, Cui H, Shen T, Liu Y, et al. SATB2 defect promotes colitis and colitis-associated colorectal cancer by impairing cl-/HCO3- exchange and homeostasis of gut microbiota. J Crohns Colitis. 2021;15(12):2088–2102. doi:10.1093/ecco-jcc/jjab094.
   PubMed Web of Science ®Google Scholar
• Zhang N, Wang Z, Lv J, Zhang S, Liu Y, Liu T, Li W, Gong L, Zhang X, El-Omar EM, et al. Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion. Front Med. 2022;9:836369. doi:10.3389/fmed.2022.836369.
   Web of Science ®Google Scholar
• Zegarra Ruiz DF, Kim DV, Norwood K, Saldana-Morales FB, Kim M, Ng C, Callaghan R, Uddin M, Chang L-C, Longman RS, et al. Microbiota manipulation to increase macrophage IL-10 improves colitis and limits colitis-associated colorectal cancer. Gut Microbes. 2022;14(1):2119054. doi:10.1080/19490976.2022.2119054.
   PubMed Web of Science ®Google Scholar
• Coker OO, Liu C, WKK W, Wong SH, Jia W, Sung JJY, Yu J. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers. Microbiome. 2022;10:35. doi:10.1186/s40168-021-01208-5.
   PubMed Web of Science ®Google Scholar
• Tikka C, Manthari RK, Ommati MM, Niu R, Sun Z, Zhang J, Wang J. Immune disruption occurs through altered gut microbiome and NOD2 in arsenic induced mice: correlation with colon cancer markers. Chemosphere. 2020;246:125791. doi:10.1016/j.chemosphere.2019.125791.
   PubMed Web of Science ®Google Scholar
• Khalyfa A, Qiao Z, Raju M, Shyu CR, Coghill L, Ericsson A, Gozal D. Monocarboxylate transporter-2 expression restricts tumor growth in a murine model of lung cancer: a multi-omic analysis. Int J Mol Sci. 2021;22(19):10616. doi:10.3390/ijms221910616.
   PubMed Web of Science ®Google Scholar
• Chao X, Lei Z, Hongqin L, Ziwei W, Dechuan L, Weidong D, Lu X, Haitao C, Bo Z, Haixing J, et al. Faeces from malnourished colorectal cancer patients accelerate cancer progression. Clin Nutr. 2022;41(3):632–644. doi:10.1016/j.clnu.2022.01.001.
   PubMed Web of Science ®Google Scholar
• Patrizz A, Dono A, Zorofchian S, Hines G, Takayasu T, Husein N, Otani Y, Arevalo O, Choi HA, Savarraj J, et al. Glioma and temozolomide induced alterations in gut microbiome. Sci Rep. 2020;10(1):21002. doi:10.1038/s41598-020-77919-w.
   PubMed Web of Science ®Google Scholar
• Fan Y, Su Q, Chen J, Wang Y, He S. Gut microbiome alterations affect glioma development and Foxp3 expression in tumor microenvironment in mice. Front Oncol. 2022;12:836953. doi:10.3389/fonc.2022.836953.
   PubMed Web of Science ®Google Scholar
• Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang RF. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. J Neuroinflammation. 2019;16(1):53. doi:10.1186/s12974-019-1434-3.
   PubMed Web of Science ®Google Scholar
• Wan G, Xie M, Yu H, Chen H. Intestinal dysbacteriosis activates tumor-associated macrophages to promote epithelial-mesenchymal transition of colorectal cancer. Innate Immun. 2018;24(8):480–489. doi:10.1177/1753425918801496.
   PubMed Web of Science ®Google Scholar
• Xu S, Liu Z, Lv M, Chen Y, Liu Y. Intestinal dysbiosis promotes epithelial-mesenchymal transition by activating tumor-associated macrophages in ovarian cancer. Pathog Dis. 2019;77(2):ftz019. doi:10.1093/femspd/ftz019.
   PubMed Web of Science ®Google Scholar
• Bader JE, Enos RT, Velázquez KT, Carson MS, Nagarkatti M, Nagarkatti PS, Chatzistamou I, Davis JM, Carson JA, Robinson CM, et al. Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer. Am J Physiol Gastrointest Liver Physiol. 2018;314(1):G22–G31. doi:10.1152/ajpgi.00229.2017.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy T, Chung D, Lochhead P, Hold G, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host & Microbe. 2013;14(2):207–215. doi:10.1016/j.chom.2013.07.007.
   PubMed Web of Science ®Google Scholar
• Xu C, Fan L, Lin Y, Shen W, Qi Y, Zhang Y, Chen Z, Wang L, Long Y, Hou T, et al. Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization. Gut Microbes. 2021;13(1):1980347. doi:10.1080/19490976.2021.1980347.
   PubMed Web of Science ®Google Scholar
• Temraz S, Nassar F, Nasr R, Charafeddine M, Mukherji D, Shamseddine A. Gut microbiome: a promising biomarker for immunotherapy in colorectal cancer. Int J Mol Sci. 2019;20(17):4155. doi:10.3390/ijms20174155.
   PubMed Web of Science ®Google Scholar
• Beamer MA, Zamora C, Nestor-Kalinoski AL, Fernando V, Sharma V, Furuta S. Novel 3D flipwell system that models gut mucosal microenvironment for studying interactions between gut microbiota, epithelia and immunity. Sci Rep. 2023;13(1):870. doi:10.1038/s41598-023-28233-8.
   PubMed Web of Science ®Google Scholar
• Routy B, Lenehan JG, Miller WH, Jamal R, Messaoudene M, Daisley BA, Hes C, Al KF, Martinez-Gili L, Punčochář M, et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat Med. 2023;29(8):2121–2132. doi:10.1038/s41591-023-02453-x.
   PubMed Web of Science ®Google Scholar
• Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, Adler K, Dick-Necula D, Raskin S, Bloch N, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Sci. 2021;371(6529):602–609. doi:10.1126/science.abb5920.
   PubMed Web of Science ®Google Scholar
• Hu Y, Li J, Ni F, Yang Z, Gui X, Bao Z, Zhao H, Wei G, Wang Y, Zhang M, et al. CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies. Nat Commun. 2022;13(1):5313. doi:10.1038/s41467-022-32960-3.
   PubMed Web of Science ®Google Scholar
• Wang F, He MM, Yao YC, Zhao X, Wang ZQ, Jin Y, Luo HY, Li JB, Wang FH, Qiu MZ, et al. Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis. Cell Rep Me. 2021;2(9):100383. doi:10.1016/j.xcrm.2021.100383.
   Google Scholar
• Shiao SL, Kershaw KM, Limon JJ, You S, Yoon J, Ko EY, Guarnerio J, Potdar AA, McGovern DPB, Bose S, et al. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy. Cancer Cell. 2021;39(9):1202–1213.e6. doi:10.1016/j.ccell.2021.07.002.
   PubMed Web of Science ®Google Scholar
• Chiang NJ, Hou YC, Tan KT, Tsai HW, Lin YJ, Yeh YC, Chen LT, Hou YF, Chen MH, Shan YS, et al. The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma. Hepatol Int. 2022;16(5):1137–1149. doi:10.1007/s12072-022-10346-3.
   PubMed Web of Science ®Google Scholar
• Ren W, Wang X, Yang M, Wan H, Li X, Ye X, Meng B, Li W, Yu J, Lei M, et al. Distinct clinical and genetic features of hepatitis B virus–associated follicular lymphoma in Chinese patients. Blood Adv. 2022;6(9):2731–2744. doi:10.1182/bloodadvances.2021006410.
   PubMed Web of Science ®Google Scholar
• Li X, Qi M, He K, Liu H, Yan W, Zhao L, Jia Y, He L, Lv C, Zhang M, et al. Neospora caninum inhibits tumor development by activating the immune response and destroying tumor cells in a B16F10 melanoma model. Parasites Vectors. 2022;15(1):332. doi:10.1186/s13071-022-05456-8.
   PubMed Web of Science ®Google Scholar
• Malik A, Sharma D, Malireddi RKS, Guy CS, Chang TC, Olsen SR, Neale G, Vogel P, Kanneganti TD. SYK-CARD9 signaling axis promotes gut fungi-mediated inflammasome activation to restrict colitis and colon cancer. Immunity. 2018;49(3):515–530.e5. doi:10.1016/j.immuni.2018.08.024.
   PubMed Web of Science ®Google Scholar
• Yang X, Guo Y, Chen C, Shao B, Zhao L, Zhou Q, Liu J, Wang G, Yuan W, Sun Z, et al. Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment. Immunology. 2021;164(3):476–493. doi:10.1111/imm.13397.
   PubMed Web of Science ®Google Scholar
• Rohm TV, Fuchs R, Müller RL, Keller L, Baumann Z, Bosch AJT, Schneider R, Labes D, Langer I, Pilz JB, et al. Obesity in humans is Characterized by gut inflammation as shown by pro-inflammatory intestinal macrophage accumulation. Front Immunol. 2021;12:668654. doi:10.3389/fimmu.2021.668654.
   PubMed Web of Science ®Google Scholar
• Pingili AK, Chaib M, Sipe LM, Miller EJ, Teng B, Sharma R, Yarbro JR, Asemota S, Al Abdallah Q, Mims TS, et al. Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer. Cell Rep. 2021;35(12):109285. doi:10.1016/j.celrep.2021.109285.
   PubMed Web of Science ®Google Scholar
• Kushwaha V, Rai P, Varshney S, Gupta S, Khandelwal N, Kumar D, Nilkanth Gaikwad A. Sodium butyrate reduces endoplasmic reticulum stress by modulating CHOP and empowers favorable anti-inflammatory adipose tissue immune-metabolism in HFD fed mice model of obesity. Food Chem(oxf). 2022;4:100079. doi:10.1016/j.fochms.2022.100079.
   Web of Science ®Google Scholar
• Li F, Hao S, Gao J, Jiang P. EGCG alleviates obesity-exacerbated lung cancer progression by STAT1/SLC7A11 pathway and gut microbiota. J Nutr Biochem. 2023;120:109416. doi:10.1016/j.jnutbio.2023.109416.
   PubMed Web of Science ®Google Scholar
• Shu Y, Cheng P. Targeting tumor-associated macrophages for cancer immunotherapy. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188434. doi:10.1016/j.bbcan.2020.188434.
   PubMed Web of Science ®Google Scholar
• Germano G, Frapolli R, Belgiovine C, Anselmo A, Pesce S, Liguori M, Erba E, Uboldi S, Zucchetti M, Pasqualini F, et al. Role of macrophage targeting in the antitumor activity of trabectedin. Cancer Cell. 2013;23(2):249–262. doi:10.1016/j.ccr.2013.01.008.
   PubMed Web of Science ®Google Scholar
• Rodell CB, Arlauckas SP, Cuccarese MF, Garris CS, Li R, Ahmed MS, Kohler RH, Pittet MJ, Weissleder R. TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy. Nat Biomed Eng. 2018;2(8):578–588. doi:10.1038/s41551-018-0236-8.
   PubMed Web of Science ®Google Scholar
• Liu Z, Xie Y, Xiong Y, Liu S, Qiu C, Zhu Z, Mao H, Yu M, Wang X. TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages. Cancer Lett. 2020;469:173–185. doi:10.1016/j.canlet.2019.10.020.
   PubMed Web of Science ®Google Scholar
• Pathria P, Louis TL, Varner JA. Targeting tumor-associated macrophages in cancer. Trends Immunol. 2019;40(4):310–327. doi:10.1016/j.it.2019.02.003.
   PubMed Web of Science ®Google Scholar